SGX    Last:21.74    -0.14

SGX

Your are welcome. 
Regardless vested or not just my humble contributions to the investing community in this forum to keep them updated on their investments.

chengwh1      ( Date: 05-Mar-2026 19:09) Posted: Thank you too on this side, Jurong.

 

let me guess.. tmr..... SBB 250k share between 1740 and 1800

 

Thank you too on this side, Jurong.

 

SBB today - 200,000 shares bought at $17.53 to $17.70 ($3,534,584)

 

SBB today - 250,000 shares bought at $17.25 to $17.70 ($4,406,368)

 

SBB on 26 Feb - 200,000 shares bought at $17.91 & $17.92 ($3,587,436)

 

It must touch 20 soon with all those collaborations

 

Navigating forward guidance on the SGX: The legal landscape in Singapore

In the dynamic global capital markets, forward-looking disclosures, or &ldquo forward guidance&rdquo , have become an increasingly prominent feature for listed companies. 

Investors increasingly seek insights into anticipated performance and strategy and the Singapore Exchange Regulation (SGX RegCo) has recently been encouraging such disclosures in order to enhance market transparency and investor confidence. 

However, this raises an important question: How far can disclosures in forward-looking statements go before becoming legally unacceptable, exposing companies and directors to scrutiny and potential liability? 

A Jan 16 SGX RegCo Guidance column, Forward Guidance &ndash Why It Matters And How To Get It Right, reframes guidance as an opportunity, emphasising that good-faith guidance, with a reasonable basis and appropriate qualifications, should not ordinarily attract regulatory scrutiny. This aligns with the initiatives of the Equity Market Development Programme, promoting corporate-investor engagement and market clarity.

It is often the case that forward guidance is disseminated through multiple channels, such as results briefings, analyst calls, investor presentations and media interactions, on top of formal announcements on SGXNet, and collectively, they could form part of the information that investors rely on when making investment decisions. 

This gives rise to distinct legal and governance considerations, as market expectations may be shaped by the cumulative effect of statements made across different platforms, audiences and time frames.

In this environment, inconsistencies, selective emphasis or informal remarks may assume greater significance when viewed in aggregate, underscoring the importance of disciplined messaging, internal coordination and appropriate board-level oversight of forward-looking communications within the constraints of Singapore&rsquo s disclosure regime.

 

SGX must find &lsquo sweet spot&rsquo in culling underperforming firms as regional peers tighten curbs: market experts

The challenge lies in balancing market quality with competitiveness, say market observers

[SINGAPORE] The Singapore Exchange (SGX) may need to calibrate its current approach in dealing with underperforming companies, particularly as regional peers tighten rules on so-called &ldquo zombie&rdquo firms, market observers say.

The term &ldquo zombie firm&rdquo emerged in the 1980s and gained prominence in the 1990s, when economists linked the persistence of weak, heavily indebted companies to Japan&rsquo s economic stagnation.

&ldquo Most of us will describe them as loss-making firms that do not seem to be creating a semblance of progress,&rdquo said James Leong, chief executive of Singapore-based asset manager Grasshopper Asia.

Such problematic firms are not unique to Singapore, with Japan and Korea also having a significant share of companies that report persistently negative returns.

Even though such companies exist, the financial watch list was removed in October as part of a shift to a more transparent disclosure-based regime by Singapore Exchange Regulation (SGX RegCo).

The bourse regulator acknowledged feedback from a public consultation in May 2025 that the watch list might hinder companies&rsquo ability to secure funding or attract customers, depress share prices and restrict investor exit opportunities.

Getting &ldquo zombie firms&rdquo back into shape

In Korea, there have been drastic moves to tighten delisting criteria. For example, starting from Jul 1, companies with a market capitalisation below 20 billion won (S$17.5 million) will be delisted from the Kosdaq market. The threshold will rise to 30 billion won at the start of 2027.

With Japan keeping up its focus on corporate governance reforms, something it started in 2022, many firms with low market capitalisation continue to delist. In 2025, a record number of 125 companies left the Tokyo Stock Exchange.

Lee Ooi Keong, managing director at board and C-suite advisory firm Clover Point Consultants, is concerned that &ldquo SGX has moved in the wrong direction on zombie firm discipline&rdquo .

He said the stigma and self-fulfilling prophecies provided some justification for the removal of the financial watch list, but cautioned that &ldquo the cure may be worse than the disease&rdquo .

Lee pointed out that SGX had earlier removed its minimum trading price watch list in 2020.

&ldquo Removing these (watch lists) as well as the delisting regulations simply allows loss-making or suspended stocks to remain on the SGX for a very long time,&rdquo he added.

Professor Mak Yuen Teen, director of the Centre for Investor Protection at NUS Business School, considers it &ldquo a mistake to totally remove mechanisms for culling zombie firms&rdquo .

In his view, at least one such safeguard should have been retained, specifically the financial watch list. He suggested that the framework could have been strengthened by adding a criterion covering companies that receive a disclaimer of opinion or a qualified opinion from auditors.

The financial watch list required companies to improve their fundamentals and achieve profitability. It targeted firms with three consecutive years of losses, giving them two years to turn their performance around.

However, there are arguments against such &ldquo label-based&rdquo mechanisms.

Jimmy Seet, capital markets partner at PwC Singapore, explained watch lists can become self-fulfilling, further restricting funding options for otherwise recoverable businesses.

Instead, SGX relies on disclosure requirements, including mandatory reporting of a third and subsequent consecutive year of losses.

&ldquo This continued requirement ensures that investors remain informed about a company&rsquo s financial health, thereby supporting informed decision-making without the need for label-specific watch lists,&rdquo Seet added.

Replacing watch lists with disclosure requirements, Clover Point Consultants&rsquo Lee noted, puts the onus on investors to act on that information.

Finding that sweet spot

Beyond the debate over watch lists, market observers say the broader challenge for SGX lies in balancing market quality with competitiveness.

Grasshopper&rsquo s Leong believes liquidity is a more pressing issue than &ldquo zombie firms&rdquo .

The deeper structural constraint, he said, is limited trading interest in smaller local counters. Instead, retail investors seeking small-cap opportunities often gravitate towards larger, more liquid markets such as Nasdaq or Hong Kong Exchange.

When it comes to zombie firms, Lee pointed to SGX&rsquo s Catalist board as a key area of concern. About 59 per cent of companies listed there are unprofitable, while 86 per cent are trading below their initial public offer price.

&ldquo Catalist has a higher incidence of loss-making companies and accounts for less than 1 per cent of market capitalisation despite being a third of all listings,&rdquo he added.

Leong also cautioned that if a large number of low-quality and lightly regulated companies are allowed to list on the Catalist board without being required to improve their performance, it could become a concern.

&ldquo In various other markets, they are required to generate more revenues or increase market caps&hellip those are good mandates,&rdquo he added.

PwC&rsquo s Seet said: &ldquo In my view, the &lsquo sweet spot&rsquo lies in a regime that enforces high standards of disclosure, governance and market conduct.&rdquo

Additionally, he sees regulatory support for non-performing listed companies to pursue restructuring and turnaround plans as beneficial &ndash helping to maintain SGX&rsquo s competitiveness relative to its peers.

 

sgx need to put in tick rule like us .
sgx need to provide t+2 share register online.
this is fair to people who put in real money for the listed business actions.
shorts action is need for liquidity. organized short is taking away long term growth of sgx.
think about it, if us and hkex has these sgx no have is it not loosing out to competition.
 

 

XDate day today for 3rd interim divdiend !

moonsun      ( Date: 12-Feb-2026 18:47) Posted: Make spore equities great again ! Budget.. Why drop ?

 

No sweat, bro,... some holders are selling on XDate. I' m confident it will EASILY climb back up to $19.07 which was the closing price on Last Day to Buy/Sell (LDTB/S),.... and even beyond...... This ctr is all about capital gain in today' s times,....

Newcomer19707016      ( Date: 12-Feb-2026 18:04) Posted: Sgx down to $18.56 today. Drop a lots

 

Make spore equities great again !
Budget..
Why drop ?

 

Sgx down to $18.56 today. Drop a lots

 

For tracking purposes :-
SGX Closed at $19.07 yesterday,...
XDate today, SGX Opened at $19.00, Dropped to $18.49 now, Lost 58c from yesterday close.
Dividend amt was 11c.

Let' s see when will it bounce back to LDTD/B price,.....  Just fooling around here,...

SGX - GO, GO, GO,... EQDP, SGX-NASDAQ Linkage, what else,... ??? 

 

STI up, SGX up !!!!!!!!!!! Breached 5k points for STI !!!!!!

 

Sgx got more good news. Congratulation to all when it passes $20, MrBear

 

broken! now to conquer 20

Newcomer19707016      ( Date: 05-Feb-2026 16:22) Posted: I can't hold for long. Hope it can break $18.50 soon.

 

Not yet, eligible to draw my cpf balance next year though.
What accounts lecturer shared has shaped how I see SGX. Monopoly biz, bulls people buy in euphoria, bears people sell in panic. Either way sgx wins. Waiting for it to either trade in 10s so more liquidity or stock split or bonus issue.

JurongW      ( Date: 05-Feb-2026 16:30) Posted: Wow, this price was more than 20 years ago. Are you in your 60s? Nippon72      ( Date: 05-Feb-2026 15:54) Posted: Never say never for SGX. With the efforts and collaboration SGX is exploring. My 2000 shares of SGX at 1.71 using cpf forms part of my bequest or trust to my kids. If it ever reaches $50 0r $100 (I may not see it), hopefully my kids do.  Keep till date cos didn' t find a reason to sell it since I don' t need the money yet. Gives me the bragging rights on Divvy interest upon my cost.  The Time to Sell, I wish is Never!

 

Yes, u entitled to the dividends after it goes XD.  If u sell when it is still CD, then no dividends.

Newcomer19707016      ( Date: 11-Feb-2026 18:55) Posted: Tomorrow sgx ex-dividend. If I sell the sgx shares tomorrow, will I be getting the dividends?